Kidney, Polycystic, Autosomal Dominant Clinical Trial
NCT number | NCT00067977 |
Other study ID # | ADPKD |
Secondary ID | |
Status | Not yet recruiting |
Phase | N/A |
First received | September 3, 2003 |
Last updated | November 2, 2005 |
This study will determine whether certain blood pressure medications will slow cyst growth or keep kidneys functioning longer in patients with autosomal dominant polycystic kidney disease (ADPKD). The study will take place at several sites in the United States. The start date of the study has not yet been determined.
Status | Not yet recruiting |
Enrollment | 0 |
Est. completion date | |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 15 Years to 65 Years |
Eligibility |
- Previous diagnosis of autosomal dominant polycystic kidney disease by abdominal
imaging - Previous diagnosis of high blood pressure or current blood pressures above 130/80 mm Hg |
Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Emory University | Atlanta | Georgia |
United States | Beth Israel Deaconess Medical Center | Boston | Massachusetts |
United States | Tufts - New England Medical Center | Boston | Massachusetts |
United States | Cleveland Clinic Foundation | Cleveland | Ohio |
United States | University of Colorado Health Sciences Center | Denver | Colorado |
United States | Kansas University Medical Center | Kansas City | Kansas |
United States | Mayo Clinic | Rochester | Minnesota |
Lead Sponsor | Collaborator |
---|---|
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
United States,
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT00784030 -
High Water Intake to Slow Progression of Polycystic Kidney Disease
|
N/A | |
Completed |
NCT00571909 -
Autosomal Dominant Polycystic Kidney Disease (ADPKD) Pain Study
|
N/A | |
Recruiting |
NCT00890279 -
Efficacy and Safety Study of Second-Line Treatment for Hypertension With Autosomal Dominant Polycystic Kidney Disease(ADPKD)
|
Phase 2 | |
Unknown status |
NCT00541853 -
CCB Safety Study in Treatment of Hypertension of ADPKD
|
Phase 4 |